Market Value1,563,601,999
Total Holdings52
File Date2023-05-11
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ISRG / Intuitive Surgical, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
CYTK / Cytokinetics, Incorporated
14161H108 / Cardtronics PLC
RXDX / Prometheus Biosciences Inc
AVTE / Aerovate Therapeutics, Inc.
CINC / CinCor Pharma Inc
INZY / Inozyme Pharma, Inc.
NVCR / NovoCure Limited Call
ASND / Ascendis Pharma A/S
ALNY / Alnylam Pharmaceuticals, Inc.
GERN / Geron Corporation
GERN / Geron Corporation Call
MRNS / Marinus Pharmaceuticals, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
SRPT / Sarepta Therapeutics, Inc.
KURA / Kura Oncology, Inc.
IDYA / IDEAYA Biosciences, Inc.
OBSV / ObsEva SA.
UTHR / United Therapeutics Corporation
AXSM / Axsome Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated Call
VIR / Vir Biotechnology, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
KDNY / Chinook Therapeutics Inc
HZNP / Horizon Therapeutics Plc
KRTX / Karuna Therapeutics, Inc.
BOLT / Bolt Biotherapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc. Call
BLUE / bluebird bio, Inc.
MRK / Merck & Co., Inc.
BIIB / Biogen Inc.
KROS / Keros Therapeutics, Inc.
ALGN / Align Technology, Inc.
CTIC / CTI BioPharma Corp
CTIC / CTI BioPharma Corp Call
FUSN / Fusion Pharmaceuticals Inc.
ISEE / IVERIC bio Inc
RETA / Reata Pharmaceuticals Inc - Class A
IMGN / ImmunoGen, Inc.
IMGN / ImmunoGen, Inc. Call
EXEL / Exelixis, Inc.
RCUS / Arcus Biosciences, Inc.
PTCT / PTC Therapeutics, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
VERA / Vera Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
IMTX / Immatics N.V.
NTRA / Natera, Inc.
INBX.V / Inhibrx, Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
FULC / Fulcrum Therapeutics, Inc.
GRTX / Galera Therapeutics, Inc.
PDSB / PDS Biotechnology Corporation
DXCM / DexCom, Inc.
SPY / State Street SPDR S&P 500 ETF Trust Put
CLDX / Celldex Therapeutics, Inc.
NCNA / NuCana plc - Depositary Receipt (Common Stock)
NXTC / NextCure, Inc.
SYBX / Synlogic, Inc.
AGEN / Agenus Inc.
AGEN / Agenus Inc. Call
LLY / Eli Lilly and Company
BMRN / BioMarin Pharmaceutical Inc.
VRTX / Vertex Pharmaceuticals Incorporated